Is TBIO or SCHD a better dividend investment in 2026?

TBIO currently yields 3921.57% with a 5% 5-year dividend growth rate. SCHD yields 3.46% with 13.05% growth. The better choice depends on your goal: TBIO offers higher current income.

What is the dividend yield difference between TBIO and SCHD?

TBIO has a forward dividend yield of 3921.57% ($2.00/share annually). SCHD yields 3.46% ($1.06/share annually). The yield gap is 3918.11 percentage points.

Home › Compare › TBIO vs SCHD

TBIO vs SCHD: Dividend Comparison 2026

TBIO yields 3921.57% · SCHD yields 3.46%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TBIO wins by $5928317923792.10M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TBIO

● Live price

3921.57%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5928317923792.13M

Annual income

$5,645,144,171,791,441,000.00

Full TBIO calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.46%

Share price

$30.48

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$425.95

Full SCHD calculator →

Portfolio growth — TBIO vs SCHD

📍 TBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TBIO	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TBIO + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TBIO pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBIO

Annual income on $10K today (after 15% tax)

$333,333.33/yr

After 10yr DRIP, annual income (after tax)

$4,798,372,546,022,725,000.00/yr

SCHD

Annual income on $10K today (after 15% tax)

$294.40/yr

After 10yr DRIP, annual income (after tax)

$362.06/yr

At 15% tax rate, TBIO beats the other by $4,798,372,546,022,725,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBIO + SCHD for your $10,000?

TBIO: 50%SCHD: 50%

100% SCHD50/50100% TBIO

Portfolio after 10yr

$2964158961896.08M

Annual income

$2,822,572,085,895,720,400.00/yr

Blended yield

95.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on TBIO right now

TBIO

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-15.6

Piotroski

3/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBIO buys

SCHD buys

Politician	Chamber	Ticker	Type	Amount	Date
Virginia Foxx	🏢 House	$SCHD	▼ Sell	$50,001 - $100,000	2023-03-08
Steve Cohen	🏢 House	$SCHD	▲ Buy	$50,001 - $100,000	2022-07-29
Hakeem S. Jeffries	🏢 House	$SCHD	▲ Buy	$15,001 - $50,000	2021-04-12
Mikie Sherrill	🏢 House	$SCHD	▲ Buy	$100,001 - $250,000	2020-02-21

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTBIOSCHD

Forward yield	3921.57% ✓	3.46%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$5928317923792.13M ✓	$29.0K
Annual income after 10y	$5,645,144,171,791,441,000.00 ✓	$425.95
Total dividends collected	$5908985646403.93M ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TBIO vs SCHD ($10,000, DRIP)

Year	TBIO Portfolio	TBIO Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$402,857	$392,156.86	$11,226	$346.36	+$391.6K → TBIO
2	$15,195,831	$14,764,774.15	$12,572	$357.38	+$15.18M → TBIO
3	$536,754,727	$520,495,188.22	$14,046	$367.84	+$536.74M → TBIO
4	$17,756,748,906	$17,182,421,348.17	$15,660	$377.73	+$17756.73M → TBIO
5	$550,236,533,968	$531,236,812,638.47	$17,425	$387.07	+$550236.52M → TBIO
6	$15,973,499,921,404	$15,384,746,830,057.32	$19,354	$395.86	+$15973499.90M → TBIO
7	$434,496,251,181,035	$417,404,606,265,133.20	$21,461	$404.13	+$434496251.16M → TBIO
8	$11,075,986,607,305,350	$10,611,075,618,541,642.00	$23,762	$411.89	+$11075986607.28M → TBIO
9	$264,648,366,355,783,070	$252,797,060,685,966,340.00	$26,272	$419.15	+$264648366355.76M → TBIO
10	$5,928,317,923,792,128,000	$5,645,144,171,791,441,000.00	$29,010	$425.95	+$5928317923792.10M → TBIO

TBIO vs SCHD: Complete Analysis 2026

TBIO — Stock

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Full TBIO Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this TBIO vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBIO vs JEPI TBIO vs O TBIO vs KO TBIO vs MAIN TBIO vs VYM TBIO vs DGRO TBIO vs VIG TBIO vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.